Literature DB >> 8188520

Mortality among inhabitants of an HTLV-I endemic area in Japan.

K Iwata1, S Ito, H Saito, M Ito, M Nagatomo, T Yamasaki, S Yoshida, H Suto, K Tajima.   

Abstract

A community-based cohort study was conducted to clarify the risk of human T-cell leukemia virus type I (HTLV-I) infection for cause-specific deaths. A total of 1,997 individuals (751 men and 1,246 women) aged 30 or older in A-Island, Nagasaki Prefecture, Japan who had voluntarily attended annual mass health examinations, including serum HTLV-I antibody test, were followed up for a mean period of 5.3 years. In a Cox proportional hazards analysis adjusted for age at baseline, the HTLV-I seropositivity was found to be associated with mortality from all causes in men (hazard ratio (HR) 1.89; 95% confidence interval (CI) 1.01-3.54) and women (HR 1.94; 95% CI 1.16-3.22). When the effects of 2 deaths (1 man and 1 woman) from adult T-cell leukemia/lymphoma (ATL) were excluded, the mortality risk decreased slightly but was still significantly or marginally significantly greater than 1 in both men (HR 1.77; 95% CI 0.93-3.37) and women (HR 1.87; 95% CI 1.12-3.12). Further analysis of cause-specific deaths revealed a significant increase in the risk for non-neoplastic diseases but not for neoplasms excluding ATL. These findings suggest that long-term HTLV-I infection represents a health hazard greater than just that for the development of ATL. It was difficult, however, to draw a conclusion regarding the association between HTLV-I infection and cancer risk, because the number of cancer deaths was small and the incidence of cancer was not investigated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188520      PMCID: PMC5919449          DOI: 10.1111/j.1349-7006.1994.tb02087.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  33 in total

1.  Noninfectious anterior uveitis in patients infected with human T-lymphotropic virus type I.

Authors:  K Nakao; N Ohba; M Matsumoto
Journal:  Jpn J Ophthalmol       Date:  1989       Impact factor: 2.447

2.  Epidemiology of HTLV-I in Gabon (Western Equatorial Africa).

Authors:  E Delaporte; A Dupont; M Peeters; R Josse; M Merlin; D Schrijvers; B Hamono; L Bedjabaga; H Cheringou; F Boyer
Journal:  Int J Cancer       Date:  1988-11-15       Impact factor: 7.396

3.  High incidence of HTLV antibody in carriers of Strongyloides stercoralis.

Authors:  K Nakada; M Kohakura; H Komoda; Y Hinuma
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

4.  Absence of HTLV-I infection among seronegative subjects in an endemic area of Japan.

Authors:  T Kinoshita; J Imamura; H Nagai; M Ito; S Ito; S Ikeda; M Nagatomo; K Tajima; K Shimotohno
Journal:  Int J Cancer       Date:  1993-04-22       Impact factor: 7.396

5.  Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.

Authors:  Y Hinuma; H Komoda; T Chosa; T Kondo; M Kohakura; T Takenaka; M Kikuchi; M Ichimaru; K Yunoki; I Sato; R Matsuo; Y Takiuchi; H Uchino; M Hanaoka
Journal:  Int J Cancer       Date:  1982-06-15       Impact factor: 7.396

6.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.

Authors:  J E Kaplan; M Osame; H Kubota; A Igata; H Nishitani; Y Maeda; R F Khabbaz; R S Janssen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

7.  Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells.

Authors:  T Katsuki; K Katsuki; J Imai; Y Hinuma
Journal:  Jpn J Cancer Res       Date:  1987-07

8.  Human T-cell leukemia virus type I infection in hemodialysis patients.

Authors:  S Y Lee; K Mastushita; J Machida; M Tajiri; K Yamaguchi; K Takatsuki
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

9.  A new agglutination test for serum antibodies to adult T-cell leukemia virus.

Authors:  M Ikeda; R Fujino; T Matsui; T Yoshida; H Komoda; J Imai
Journal:  Gan       Date:  1984-10

10.  Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody.

Authors:  R Fujino; K Kawato; M Ikeda; H Miyakoshi; M Mizukoshi; J Imai
Journal:  Jpn J Cancer Res       Date:  1991-04
View more
  8 in total

1.  Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis.

Authors:  E Tynell; S Andersson; E Lithander; M Arneborn; J Blomberg; H B Hansson; A Krook; M Nomberg; K Ramstedt; A Shanwell; A Bjorkman
Journal:  BMJ       Date:  1998-05-09

Review 2.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

3.  HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.

Authors:  Carla van Tienen; Maarten F Schim van der Loeff; Ingrid Peterson; Matthew Cotten; Birgitta Holmgren; Sören Andersson; Tim Vincent; Ramu Sarge-Njie; Sarah Rowland-Jones; Assan Jaye; Peter Aaby; Hilton Whittle
Journal:  Retrovirology       Date:  2010-06-04       Impact factor: 4.602

4.  HTLV-1 and HIV-2 infection are associated with increased mortality in a rural West African community.

Authors:  Carla van Tienen; Maarten Schim van der Loeff; Ingrid Peterson; Matthew Cotten; Sören Andersson; Birgitta Holmgren; Tim Vincent; Thushan de Silva; Sarah Rowland-Jones; Peter Aaby; Hilton Whittle
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

5.  Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians.

Authors:  Lloyd Einsiedel; Hai Pham; Kim Wilson; Rebecca Walley; Jocelyn Turpin; Charles Bangham; Antoine Gessain; Richard J Woodman
Journal:  PLoS Negl Trop Dis       Date:  2018-03-12

6.  Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau.

Authors:  Birgitta Holmgren; Zacarias da Silva; Pernille Vastrup; Olav Larsen; Sören Andersson; Henrik Ravn; Peter Aaby
Journal:  Retrovirology       Date:  2007-11-27       Impact factor: 4.602

7.  Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors.

Authors:  K Arisawa; M Soda; M Akahoshi; T Matsuo; E Nakashima; M Tomonaga; H Saito
Journal:  Jpn J Cancer Res       Date:  1998-08

8.  Dichotomy in Fatal Outcomes in a Large Cohort of People Living with HTLV-1 in São Paulo, Brazil.

Authors:  Rosa Maria N Marcusso; Johan Van Weyenbergh; João Victor Luisi de Moura; Flávia Esper Dahy; Aline de Moura Brasil Matos; Michel E J Haziot; Jose E Vidal; Luiz Augusto M Fonseca; Jerusa Smid; Tatiane Assone; Jorge Casseb; Augusto César Penalva de Oliveira
Journal:  Pathogens       Date:  2019-12-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.